Iassist Health Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 4.07%
(FY 2022)
- Profit -66.75%
(FY 2022)
- Ebitda 90.90%
(FY 2022)
- Net Worth 14.12%
(FY 2022)
- Total Assets 38.49%
(FY 2022)
About Iassist Health
The Corporate was formerly known as Ortunet Technologies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deodutt Jakhi and Aparna Jakhi serve as directors at the Company.
- CIN/LLPIN
U72900MH2014PTC259849
- Company No.
259849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Iassist Health Private Limited offer?
Iassist Health Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Biochemistry Analyzer, IVDs & Analyzers, Hematology Analyzers, Medical Consultants & Clinics, Health Care Service, Electronic Repair Service, Medical Equipment Repair Services, Blood Gas Analyzer, Electrolyte Analyzer.
Who are the key members and board of directors at Iassist Health?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deodutt Jakhi  | Director | 05-Nov-2015 | Current |
| Aparna Jakhi | Director | 14-Jul-2017 | Current |
Financial Performance of Iassist Health.
Iassist Health Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.07% increase. The company also saw a substantial fall in profitability, with a 66.75% decrease in profit. The company's net worth Soared by an impressive increase of 14.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iassist Health?
In 2021, Iassist Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jayam Prolife Private LimitedActive 4 years 1 monthDeodutt Jakhi and Aparna Jakhi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Iassist Health?
Unlock and access historical data on people associated with Iassist Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iassist Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iassist Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
